Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether it is safe to treat lung cancer patients
who have undergone an attempt at curative resection with the combination of docetaxel and
carboplatin.